Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
One of the most common questions patients ask about ketamine therapy is straightforward: how long will the benefits last? It is a reasonable concern. The rapid onset of ketamine's antidepressant effects — sometimes within hours — is well documented. But the durability question is just as important for anyone considering treatment. A single dose that works for 24 hours is interesting pharmacology; a treatment protocol that sustains improvement over weeks is clinically transformative. The research, fortunately, has begun to address this question directly.
A pivotal study by Aan het Rot M and colleagues, published in Biological Psychiatry in 2010 (PMID: 19897179), examined the safety and efficacy of repeated-dose intravenous ketamine in patients with treatment-resistant depression. Ten patients who had failed to respond to adequate trials of at least two antidepressant medications received six ketamine infusions over a 12-day period. Depression severity was measured using the Montgomery-Asberg Depression Rating Scale (MADRS) before, during, and after the infusion series.
The results were encouraging on multiple fronts. Nine of the ten patients met response criteria (50 percent or greater reduction in MADRS scores) during the infusion phase. The median duration of sustained response after the final infusion was 19 days, though there was meaningful variability — some patients maintained improvement for weeks while others experienced symptom return more quickly. Notably, the repeated dosing approach appeared to extend the duration of benefit compared to what had been observed with single-infusion studies, where effects typically waned within one to two weeks.
Side effects during the infusion series were generally mild and transient, including dissociative symptoms, elevated blood pressure, and perceptual disturbances that resolved within hours of each infusion. No patient experienced a serious adverse event, and cognitive function was not impaired on formal testing. This safety profile across repeated administrations was an important finding, as concerns about cumulative side effects with repeated ketamine use had been a legitimate question.
From a treatment planning perspective, this study helped establish a key principle: ketamine's antidepressant effects may be extended through serial administration. This finding has informed the development of treatment protocols that use an initial series of sessions — often four to six over two to three weeks — followed by maintenance sessions at individually determined intervals.
The variability in response duration is clinically meaningful. Some patients maintain improvement for several weeks between sessions, while others may need more frequent maintenance. This underscores the importance of individualized treatment plans and ongoing physician oversight. A skilled clinician can help titrate session frequency based on symptom monitoring, gradually extending the interval between treatments as stability improves.
It is also worth noting that ketamine treatment does not exist in isolation. Many patients achieve the best outcomes when they combine ketamine with psychotherapy, lifestyle modifications, and other evidence-based interventions. The neuroplasticity window that ketamine appears to open — typically in the days following a session — may be a particularly productive time for therapeutic work.
If you are considering ketamine therapy, the honest answer to "how long does it last?" is: it varies, but most patients can expect meaningful relief lasting days to weeks per session, with the potential for longer-lasting benefits when treatment is structured as a series followed by maintenance. The initial treatment phase is not a one-and-done experience — it is more like building a foundation that then requires periodic reinforcement.
Key factors that may influence how long your response lasts include the severity and chronicity of your depression, whether you are engaged in concurrent psychotherapy, sleep quality, exercise habits, and stress management. Working closely with a physician who monitors your progress and adjusts your treatment plan accordingly is essential for optimizing durability.
Repeated ketamine administration can extend antidepressant effects beyond what a single dose provides, with a median response duration of approximately 19 days after a six-infusion series in treatment-resistant patients. Individual response varies, and a maintenance strategy guided by a physician offers the best path to sustained improvement.
Reference: Aan het Rot M, et al. "Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression." Biological Psychiatry. 2010;67(2):139-145. PMID: 19897179.
If you're considering ketamine therapy, Isha Health offers physician-led at-home treatment via telemedicine in California, New York, Texas, Florida, Colorado, Arizona, Georgia, Oregon, and Washington. No in-person visit required.
